NovaPharm-led
Programme architecture and governed coordination within an agreed scope.
Responsibilities
- Evidence assessment
- Responsibility mapping
- UK pathway coordination
- Development continuity
Clinical Research & CRO Support
Clinical development, connected to evidence and accountability.
Programme architecture and specialist coordination with sponsor responsibilities kept explicit.
Operating boundary
Focused orchestration. No unsupported full-service claim.
NovaPharm provides scoped programme coordination. It is not represented as a sponsor or full-service CRO. Specialist functions require appropriately qualified providers; sponsor duties and authority decisions remain with their accountable owners.
Emerging biotechnology and pharmaceutical developersSpecialty-pharma and product ownersInternational development organisationsSponsors using specialist providers
Responsibility model
Three delivery lanes.
Keep programme coordination, specialist delivery and sponsor-retained duties distinct.
Qualified specialist delivery
Functions requiring proven infrastructure or professional accountability.
Responsibilities
- Clinical operations
- Data and biometrics
- Medical and safety oversight
- Laboratories and specialist writing
Sponsor-retained
Duties that remain with the sponsor when activities are delegated.
Responsibilities
- Sponsor designation and duties
- Provider oversight
- Protocol and risk decisions
- Safety and compliance accountability
Operating sequence
Responsibilities before activity.
- 01
Initial discussion
Define the programme question, stage and intended decision without requesting patient-identifiable information.
- 02
Evidence and need assessment
Review non-confidential evidence, assumptions, dependencies and gaps.
- 03
Responsibility mapping
Separate sponsor, NovaPharm and specialist-provider duties before scope is agreed.
- 04
Proposed engagement route
Set the suitable work packages, evidence outputs and governance route without guaranteeing acceptance or timing.
Clinical-development questions and answers
What clinical-development support does NovaPharm provide?
NovaPharm's current public offer is centred on programme framing, UK pathway coordination, responsibility mapping, document and decision governance, specialist-vendor coordination, clinical-supply planning and development-to-market continuity.
Is NovaPharm a full-service CRO?
No. NovaPharm does not present itself as a global full-service CRO, investigator-site network, clinical-trial sponsor or in-house biometrics organisation. Functions outside its evidenced scope require appropriately qualified specialists.
Can NovaPharm coordinate specialist CRO functions?
Potentially, following programme assessment and capability mapping. Any specialist provider must be appropriately qualified, contracted and governed for the agreed function.
Does NovaPharm support UK regulatory and ethics preparation?
NovaPharm can coordinate pathway planning and evidence responsibilities with qualified regulatory contributors. MHRA authorisation and a favourable Research Ethics Committee opinion are decisions of the relevant authorities.
Can NovaPharm support clinical-supply coordination?
NovaPharm can help map clinical-supply responsibilities and coordinate qualified parties. It does not claim owned manufacturing, clinical depots or an operational IMP distribution network.
How do we begin a discussion?
Use the clinical-development enquiry route to share high-level, non-confidential programme context. Do not submit patient-identifiable data, adverse-event information or urgent medical information through the form.
Start a qualified conversation